Sept. 3, 2008 Panacea Pharmaceuticals Announces Issuance of a U.S. Patent Covering Anti-HAAH Antibodies Panacea's mission is to discover, develop and commercialize innovative therapeutic and diagnostic products. Our current product development focus is on novel proteins and biochemical pathways related to cellular regulation and cell cycle abnormalities in oncology, as well as neurodegenerative diseases such as stroke, Alzheimer's, and Parkinson's Disease.